Synapse - Alison Moskowitz

Search Within

Alison Moskowitz

Results (355)

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results

Meeting Abstract

Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Dose-adjusted EPOCH plus /- rituximab in older patients with high grade diffuse large B-cell lymphoma, Burkitt and T-cell lymphoma: An effective regimen with acceptable toxicity profile

Meeting Abstract

Owens, C. N.; Migliacci, J. C.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Younes, A.; more...
Blood (2014)

Fulltext@MSK | Save

Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
Blood (2014)

Fulltext@MSK | Save

Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma

Meeting Abstract

Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Noy, A.; Portlock, C. S.; Palomba, M. L.; Straus, D. J.; more...
Blood (2014)

Fulltext@MSK | Save

Ofatumumab-bendamustine as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk adapted design with comprehensive geriatric assessment

Meeting Abstract

Casulo, C.; Iannotta, A.; Walkley, J.; Moskowitz, C. H.; Moskowitz, A. J.; Drullinsky, P.; Zelenetz, A. D.; Hamlin, P.
Blood (2014)

Fulltext@MSK | Save

Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay

Meeting Abstract

Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
Blood (2014)

Fulltext@MSK | Save

Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience

Meeting Abstract

Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Journal Article

Carson, K. R.; Newsome, S. D.; Kim, E. J.; Wagner-Johnston, N. D.; Von Geldern, G.; Moskowitz, C. H.; Moskowitz, A. J.; Rook, A. H.; Jalan, P.; Loren, A. W.; more...
Cancer (2014)

Fulltext@MSK | Save

Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event

Journal Article

Gandhi, M. D.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
Blood (2014)

Fulltext@MSK | Save

Cutaneous ATLL is a diagnostic challenge and has heterogenous clinical and histologic features

Meeting Abstract

Marchetti, M. A.; Pulitzer, M.; Myskowski, P.; Dusza, S.; Lunning, M.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
Journal of Investigative Dermatology (2014)

Fulltext@MSK | Save